Welcome to our dedicated page for Cannabix Technol news (Ticker: BLOZF), a resource for investors and traders seeking the latest updates and insights on Cannabix Technol stock.
Cannabix Technologies Inc. develops marijuana and alcohol breath-testing technologies for workplace safety, law enforcement, and other safety-sensitive settings. Company news centers on the Marijuana Breath Test, or MBT, including its Breath Collection Unit and single-use Breath Cartridges used to collect breath samples for laboratory analysis of recent cannabis use.
Recurring updates include commercial rollout activity, deliveries through authorized resellers, product validation, regulatory and compliance testing for device hardware, and distribution or education efforts with testing-industry partners. News also covers the company’s work with Omega Laboratories on analytical methods for detecting cannabinoids in breath samples using LC-MS-based testing.
Cannabix Technologies (OTC:BLOZF), a developer of marijuana and alcohol breath testing devices, announced its participation in the inaugural cannabis breathalyzer workshop hosted by the U.S. National Institute of Standards and Technology (NIST). The workshop, titled "Building a Path Forward for Meaningful Cannabis Breathalyzer Realization," will be held at NIST's Colorado facilities in September.
The company will showcase its Marijuana Breath Test (MBT) technology, which detects recent cannabis use through delta-9-tetrahydrocannabinol (Δ9-THC) identification. The system features proprietary Breath Collection Unit (BCU) and Breath Cartridge (BC) technologies designed to collect and preserve breath samples for analysis using LC-MS methods.
Cannabix Technologies (OTC:BLOZF) announced its participation in the upcoming NSC Safety Congress & Expo in Denver, Colorado from September 15-17, 2025. The company will showcase two key products alongside distribution partner Alco Prevention Canada: the Cannabix Marijuana Breath Test (MBT) for recent THC use detection and the BreathLogix alcohol screening devices.
The BreathLogix system features real-time BAC testing with photo identification, SMS/email alerts, and integration capabilities with various access control systems. Notably, the BreathLogix "Workplace Series" device received NHTSA approval and was added to the U.S. Federal Register Conforming Products List for breath alcohol screening devices in May.
Cannabix Technologies (OTC:BLOZF) has delivered multiple Marijuana Breath Test (MBT) units to Omega Laboratories in Ohio, marking a significant step in their commercialization efforts. The technology includes proprietary Breath Collection Units (BCU) and Breath Cartridges (BC) designed to detect recent cannabis use through delta-9-tetrahydrocannabinol (Δ9-THC) detection.
The initial delivery comprises 200 Breath Cartridges and several BCUs. The companies are collaborating on manufacturing, marketing, distribution, and logistics for the MBT. Omega Laboratories, an international leader in forensic drug testing with ISO/IEC 17025 accreditation, has already delivered a Validation Packet for their Laboratory Developed Test Method to test delta-9 THC analytes.
Cannabix Technologies (OTC:BLOZF) has appointed William (Bill) R. Corl, CEO of Omega Laboratories, to its Board of Directors. Corl brings over 26 years of experience in diagnostic testing and technology solutions, with significant expertise in advancing drug screening industry standards.
The appointment strengthens the existing strategic partnership between Cannabix and Omega Laboratories, established in May 2024, focused on commercializing the company's Marijuana Breath Test (MBT) technology. Omega has already integrated Cannabix Breath Cartridges into its testing protocols and both companies are collaborating on marketing, distribution, manufacturing, and logistics for the MBT.
Cannabix Technologies (OTC:BLOZF) has received a notice of allowance from the Canadian Intellectual Property Office (CIPO) for its patent application titled "Contact-Free Breath Analysis Device and Method." This follows a similar notice from the U.S. Patent and Trademark Office for the same technology.
The patent covers dual-mode contactless breath capture and analysis technology that can be integrated into vehicles, workplaces, and public kiosks. The system features unmanned testing capabilities, real-time feedback, and intelligent airflow adjustment mechanisms, making it particularly valuable for law enforcement, workplace safety, and public health monitoring applications.
Cannabix Technologies (OTC:BLOZF) has initiated its first production run of BreathLogix alcohol screening devices, partnering with Price Electronics as their contract manufacturer. Price Electronics, with their 28,000 square foot facility in Winnipeg, brings significant credentials including ISO 13485, ISO9001, and IPC certifications.
The BreathLogix "Workplace Series" device has received National Highway Traffic Safety Association approval and has been added to the U.S. Federal Register Conforming Products List for breath alcohol screening devices. Additionally, the company has secured an exclusive distribution agreement with Breathalyser Sales & Service Pty Ltd. for Australia, New Zealand, and the Pacific Islands.
Cannabix Technologies (BLOZF) has selected Price Industries Ltd. as the contract manufacturer for its BreathLogix alcohol screening device product line. Price Electronics, with its 28,000 square foot facility in Winnipeg, holds ISO 13485, ISO9001, and IPC certifications, offering scalable manufacturing capabilities.
The company's BreathLogix "Workplace Series" device recently received National Highway Traffic Safety Association approval and was added to the U.S. Federal Register Conforming Products List for breath alcohol screen devices. Additionally, Cannabix secured an exclusive distribution agreement with Breathalyser Sales & Service Pty Ltd. for Australia, New Zealand, and Pacific Islands markets.
The company is also in discussions with U.S. and Canadian manufacturers regarding its Marijuana Breath Testing technology, including its Breath Collection Unit, Breath Cartridge technology, and disposable parts.
Cannabix Technologies (BLOZF) has secured its first international distribution agreement for its BreathLogix autonomous alcohol breathalyzer devices. The exclusive 2-year agreement with Breathalyser Sales & Service Pty Ltd. covers Australia, New Zealand, and the Pacific Islands. BreathLogix offers rapid breath alcohol testing with integrated photo capture, real-time manager alerts, and cloud reporting capabilities.
The device features patent-pending pre-calibrated sensor cartridge technology and can be integrated with various access control systems. Target markets include mining, oil and gas, industrial, trucking, and warehousing sectors. The company is also advancing its Marijuana Breath Test (MBT) technology and seeking distribution partners in the United States.